Roche (OTCMKTS:RHHBY) Rating Reiterated by Societe Generale

Last updated on Tuesday, July 27, 2021 | 2021 MarketBeat

Roche (OTCMKTS:RHHBY)'s stock had its "hold" rating restated by research analysts at Societe Generale in a research report issued to clients and investors on Tuesday, The Fly reports.

Several other analysts have also commented on RHHBY. Cowen began coverage on Roche in a report on Wednesday, July 21st. They set an "outperform" rating on the stock. Morgan Stanley reissued an "equal weight" rating on shares of Roche in a report on Thursday, June 10th. Barclays set a $46.42 price objective on Roche and gave the company an "overweight" rating in a report on Friday. Berenberg Bank reissued a "hold" rating on shares of Roche in a report on Monday, June 14th. Finally, Deutsche Bank Aktiengesellschaft raised Roche from a "hold" rating to a "buy" rating in a report on Thursday, July 8th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating to the company's stock. The company presently has an average rating of "Hold" and a consensus target price of $45.71.

Roche stock traded down $0.27 during midday trading on Tuesday, hitting $46.76. 1,725,426 shares of the company were exchanged, compared to its average volume of 992,171. The company has a market cap of $322.08 billion, a price-to-earnings ratio of 17.65, a PEG ratio of 2.20 and a beta of 0.33. Roche has a fifty-two week low of $39.72 and a fifty-two week high of $48.79. The stock's fifty day simple moving average is $46.36. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.30 and a quick ratio of 1.01.

A number of large investors have recently bought and sold shares of the business. Meeder Asset Management Inc. raised its position in Roche by 55.5% in the first quarter. Meeder Asset Management Inc. now owns 684 shares of the company's stock valued at $28,000 after purchasing an additional 244 shares during the period. First Horizon Advisors Inc. raised its position in Roche by 58.2% in the first quarter. First Horizon Advisors Inc. now owns 726 shares of the company's stock valued at $28,000 after purchasing an additional 267 shares during the period. Thomas White International Ltd. raised its position in Roche by 0.8% in the first quarter. Thomas White International Ltd. now owns 57,312 shares of the company's stock valued at $2,325,000 after purchasing an additional 464 shares during the period. Canandaigua National Corp raised its position in Roche by 2.7% in the first quarter. Canandaigua National Corp now owns 18,086 shares of the company's stock valued at $734,000 after purchasing an additional 468 shares during the period. Finally, Front Row Advisors LLC grew its stake in shares of Roche by 135.1% in the first quarter. Front Row Advisors LLC now owns 870 shares of the company's stock valued at $35,000 after buying an additional 500 shares in the last quarter. Institutional investors own 0.32% of the company's stock.

About Roche

Roche Holding AG operates as a research healthcare company. It operates through the following segments: Diagnostics and Pharmaceuticals. The Pharmaceutical segment refers to development of medicines in the field of oncology, immunology, ophthalmology, infectious diseases and neuroscience. The Diagnostic segment refers to diagnosis of diseases through an in vitro diagnostics process.

Featured Story: What is range trading?

The Fly logo

Analyst Recommendations for Roche (OTCMKTS:RHHBY)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Featured Article: What is FinTech?


7 Stocks to Buy Now and Avoid a Summer Swoon

Summer is generally a quiet time in the markets. Institutional investors, generally speaking, take some time away. In fact, that’s where the idiom “Sell in May and Go Away” comes from.

But quiet doesn’t mean uneventful. The world still moves along even in the lazy months of summer. And at the moment, there are two conflicting views driving the market.

One is the fear that everything’s a bubble that is just about to burst. We don’t recommend you get out of stocks, but let’s face it, things are more than just a little frothy.

But there’s another view summarized by the acronym, YOLO (as in You Only Live Once). And these investors are committed to keeping the markets going higher. Even if it means going “all in” (whatever that means to them) on risky asset classes like NFTs or Dogecoin.

We sincerely hope you take time to recharge (whatever that means to you) this summer. Whatever your personal beliefs, the reopening of our economy is a moment that deserves to be celebrated by all of us. But before you do, we recommend that you take a peek at these seven stocks that you can consider adding to your portfolio before you check out for the summer. These are likely to get as hot as a firecracker on the Fourth of July and should have you smiling when the summer ends.

View the "7 Stocks to Buy Now and Avoid a Summer Swoon".


MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.